Share

The key list

Powered by

Leading generics companies globally by revenue

This month our power industry key list brings you the 15 largest generics companies globally by revenue, as ranked by GlobalData's Power Intelligence Centre. All numbers as of June 2020.

Company nameAnnual revenue ($million)Headquarters locationNumber of employees

Teva Pharmaceutical Industries Ltd

18,854Israel40,039

Mylan NV

11,434UK35,000

Fresenius Kabi AG

7,021Germany33,195

Perrigo Co Plc

4,732Ireland11,200

Sun Pharmaceutical Industries Ltd

4,072India30,000

Aspen Pharmacare Holdings Ltd

3,098South Africa9,965

Endo International Plc

2,947Ireland3,172

Aurobindo Pharma Ltd

2,537India17,332

Lupin Ltd

2,430India17,042

Cipla Ltd

2,340India24,750

Dr. Reddy's Laboratories Ltd

2,195India21,966

Cadila Healthcare Ltd

1,838India23,500

Intas Pharmaceuticals Ltd

1,674India-

Krka dd Novo Mesto

1,572Slovenia11,390

Wockhardt Ltd

605India5,840

Share this article

Go to article: Home | Breaking the BarrierGo to article: In this issueGo to article: NSFGo to article: ContentsGo to article: AlmacGo to article: NewsGo to article: VEGA Company Insight Go to article: VEGA AustraliaGo to article: Covid-19 executive briefing by GlobalDataGo to article: Gilead’s remdesivir a candidate for US government stockpiling or bulk buying in Go to article: Covid-19’s impact on trial PROs, other endpoints can be addressed via data stratification, sensitivity analysisGo to article: ILC Dover Go to article: Vitamin D affects Covid-19 mortalityGo to article: Clinical trial disruption due to Covid-19 has begun to slowGo to article: Covid-19 boosts big bio/pharma drug sales but Regeneron may be falling shortGo to article: MimotopesGo to article: The pharma industry briefingGo to article: Charting the ups and downs of the World Health OrganizationGo to article: Road to RECOVERY: a deep dive into the world’s largest Covid-19 drug trialGo to article: Salvaging clinical trials in the time of Covid-19Go to article: Intellectual property in the time of Covid-19Go to article: Molnár-Institute Company InsightGo to article: Molnar-InstituteGo to article: A plight for sore eyes: the latest developments in seasonal allergy treatmentGo to article: How research groups are tackling the problem of biologic drug delivery Go to article: Breaking the blood-brain barrier: neurology’s greatest challengeGo to article: Timeline: charting the history of immunotherapy, cancer treatment's fourth pillarGo to article: Creating a sure data footing for AIGo to article: Koehler eClinicalGo to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: EventsGo to article: Next issue